During the past decade, Terveystalo Turku Kuvantaminen conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Turku Kuvantaminen" #1 collaborator was "BioMS Technology Corp." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Terveystalo Turku Kuvantaminen" are "Secondary Progressive Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Terveystalo Turku Kuvantaminen" in a lesser frequency.

Most popular intervention types in "Terveystalo Turku Kuvantaminen" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "dirucotide" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Terveystalo Turku Kuvantaminen" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Terveystalo Turku Kuvantaminen". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Terveystalo Turku Kuvantaminen, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Terveystalo Turku Kuvantaminen, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".